Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous levetiracetam for acute seizures
ACTRN12608000293369Phase 4Not yet recruiting
- Sponsor
- Prof. David C. Reutens
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of levetiracetam in epilepsy and seizure disorder, sponsored by Prof. David C. Reutens. Primary endpoint: Termination/control of acute seizure after intravenous levetiracetam infusion. Planned start Jun 2008; status: not yet recruiting.
02
Drugs
levetiracetam
03
Conditions
epilepsyseizure disorder
Beyond the preview
Go deeper on ACTRN12608000293369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000293369.